Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.
The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.
Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.
Prior Performance
The post AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth first appeared on AlphaStreet.
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues. The company reported worldwide net revenues of
The post AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth first appeared on AlphaStreet.
Categories AlphaGraphs, Earnings, Health Care
AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.
The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.
Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don’t miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Amazon (AMZN) likely to report higher sales and profit for Q4 2024
Amazon.com Inc. (NASDAQ: AMZN) has concluded another strong fiscal year and is preparing to report results for the final three months of FY24. The e-commerce giant has been investing heavily
What to look for when Philip Morris (PM) reports Q4 2024 earnings results
Shares of Philip Morris International Inc. (NYSE: PM) stayed red on Monday. The stock has gained 42% over the past 12 months. The tobacco giant is slated to report its fourth
TSN Earnings: Tyson Foods reports better-than-expected Q1 sales and profit
Tyson Foods, Inc. (NYSE: TSN) Monday announced financial results for the first quarter of 2025, reporting higher sales and earnings that beat Wall Street’s estimates. The food processing company’s first-quarter
Tags